APA

Galili N. B., Mehdi M., Mumtaz M., Miron P., Woda B., Al-Homsi S., Westervelt P. & Raza A. (20060928). Can molecular profiling of cytogenetic subgroups draw a roadmap for individualizing therapy in myelodysplastic syndromes?. : Future oncology (London, England).

Chicago

Galili Naomi Bruce, Mehdi Murtaza, Mumtaz Muhammad, Miron Patricia, Woda Bruce, Al-Homsi Samer, Westervelt Peter and Raza Azra. 20060928. Can molecular profiling of cytogenetic subgroups draw a roadmap for individualizing therapy in myelodysplastic syndromes?. : Future oncology (London, England).

Harvard

Galili N. B., Mehdi M., Mumtaz M., Miron P., Woda B., Al-Homsi S., Westervelt P. and Raza A. (20060928). Can molecular profiling of cytogenetic subgroups draw a roadmap for individualizing therapy in myelodysplastic syndromes?. : Future oncology (London, England).

MLA

Galili Naomi Bruce, Mehdi Murtaza, Mumtaz Muhammad, Miron Patricia, Woda Bruce, Al-Homsi Samer, Westervelt Peter and Raza Azra. Can molecular profiling of cytogenetic subgroups draw a roadmap for individualizing therapy in myelodysplastic syndromes?. : Future oncology (London, England). 20060928.